Cyclosporine microemulsion

DRUG5 trials

Sponsors

Astellas Pharma Inc, Novartis, Samsung Medical Center

Conditions

Dry Eye SyndromesKidney TransplantKidney TransplantationLiver Transplant

Phase 3

Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients

CompletedNCT00064701

Astellas Pharma IncKidney Transplantation

Start: 2003-06-30End: 2009-03-31Updated: 2013-12-05

Phase 4

Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients

CompletedNCT00171743

NovartisLiver Transplant

Start: 2004-04-30End: 2006-01-31Updated: 2017-06-07

Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients

CompletedNCT00171496

NovartisKidney Transplant

Start: 2003-10-31End: 2006-03-31Updated: 2016-11-18

Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients

CompletedNCT00171509

NovartisLiver Transplant

Start: 2004-05-31End: 2005-10-31Updated: 2011-02-01

The Effect of Cyclosporin Before Cataract Surgery

CompletedNCT04426240

Samsung Medical CenterDry Eye Syndromes

Start: 2020-08-03End: 2022-04-19Updated: 2022-05-13